Nevertheless, inhibition of COX enzymatic activity by NSAIDs (non-steroidal anti-inflammatory drugs) has different consequences depending on the timing of AD development, and inhibition of COX-1/COX-2 by non-selective NSAIDs is beneficial in preventing disease in healthy aging individuals but ineffectual once symptoms begin71,72. Here, PTGS2 is linked to Alzheimer disease.